Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: PTSC vs TPL issue - All
1
Apr 17, 2010 09:44PM

Apr 17, 2010 10:17PM
6
Apr 17, 2010 10:49PM
2
Apr 18, 2010 09:50AM

< took another look at the recent 10Q and PR looking for the source of all the concerns voiced here recently.>

<In December 2009 and January 2010, we provided operational funding by loaning TPL $950,000 and $1,000,000, respectively. The $1,000,000 note which was due to be repaid by February 28, 2010 is currently in default, and we have provided a full allowance against this receivable. We do not anticipate making additional loans to TPL, and its ability to access liquidity from other sources is not certain.>

Actually, I think the underlined portion regarding TPL's ability to access liquidity is perhaps a major point of concern/wonder/guessing.

Why did PTSC feel it was necessary to include that information?

Opty

3
Apr 18, 2010 02:57PM
2
Apr 18, 2010 04:23PM
1
Apr 18, 2010 04:24PM
6
Apr 18, 2010 04:54PM
1
Apr 18, 2010 06:16PM

Apr 19, 2010 08:47AM
4
Apr 19, 2010 12:31PM
6
Apr 19, 2010 12:42PM
Share
New Message
Please login to post a reply